ABSTRACT
Post-operative endophthalmitis is an infection and an inflammation of the eye following a surgical procedure. Its treatment is based on drug injections into the eye. However, this treatment can lead to ocular complications. Intraocular implants could substitute the conventional therapy. Poly(lactic-co-glycolic acid) (PLGA) implants comprising on vancomycin and dexamethasone were evaluated as drug delivery system to treat endophthalmitis after cataract surgery. Implants were characterized by drug content uniformity, Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), Wide Angle X-ray Scattering (WAXS), Scanning Electron Microscopy (SEM) and in vitro drug release. The bactericidal effect of vancomycin, eluted from the implants, was demonstrated against Staphylococcus aureus and Staphylococcus epidermidis. The drugs were uniformly distributed in the polymer. The analytical techniques revealed the chemical integrity of the drugs incorporated into the polymer and the modification of dexamethasone semi-crystalline nature. Drugs were controlled released from implants; and the eluted vancomycin showed bactericidal effects. In conclusion, PLGA implants containing vancomycin and dexamethasone may represent a therapeutic alternative to treat post-operative endophthalmitis.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Bacteria/drug effects , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Drug Carriers , Lactic Acid , Polyglycolic Acid , Surgical Wound Infection/prevention & control , Vancomycin/administration & dosage , Vancomycin/therapeutic use , Anti-Bacterial Agents/pharmacology , Drug Implants , Drug Liberation , Endophthalmitis/microbiology , Endophthalmitis/prevention & control , Humans , Microbial Sensitivity Tests , Ophthalmologic Surgical Procedures , Polylactic Acid-Polyglycolic Acid Copolymer , Staphylococcus aureus/drug effects , Staphylococcus epidermidis/drug effects , Vancomycin/pharmacologyABSTRACT
Avaliaram-se iogurtes de leite de cabra contendo ou não Bifidobacterium longum, B. breve, B. pseudolongum ou B. bifidum, adicionados ou não de aroma de morango. Os dados obtidos nas análises higiênico-sanitárias e físico-químicas foram dentro dos valores exigidos pela legislação brasileira; apenas o valor encontrado para lactose esteve abaixo do recomendado. Quanto às bactérias do iogurte, não houve diferença na contagem de Streptococcus salivarius subsp. thermophilus durante a estocagem, e não foi detectado Lactobacillus delbrueckii subsp. bulgaricus nas diluições utilizadas. A enumeração de Bifidobacterium spp. manteve-se entre 10(6) e 10(8)UFC/mL e não diferiu entre as espécies ao longo do tempo. Considerando-se a adição ou não de aroma, a análise das variáveis tempo e aroma não mostrou diferença estatística. A contagem entre os Bifidobacterium spp. demonstrou que nenhum microrganismo apresentou um comportamento superior a outro. Na análise sensorial, as amostras de iogurtes adicionados ou não de Bifidobacterium spp. e adicionados de aroma de morango não apresentaram diferenças entre si. O estudo mostrou ser possível a elaboração de iogurte de leite de cabra adicionado de Bifidobacterium spp. e de aroma de morango com qualidade assegurada, potencial para uso probiótico e boa aceitação pelo consumidor.
Goat milk yogurt with or without Bifidobacterium longum, B. breve, B. pseudolongum, or B. bifidum, and supplemented or not with strawberry aroma were evaluated. Data obtained from hygienic-sanitary and physicochemical analyses were within the values recommended by the Brazilian legislation, except for lactose contents, which were lower than the recommended. In relation to the yogurt bacteria, there was no difference in the counts of Streptococcus salivarius subsp. thermophilus during the storage, and Lactobacillus delbrueckii subsp. bulgaricus was not detected. The counts of Bifidobacterium spp.ranged from 10(6) to 10(8)CFU/mL, without difference between the species along the time. Considering the addition of flavor or not, the analysis of aroma and time variables showed no statistical difference. The counts of Bifidobacterium spp. demonstrated that none showed a superior value. For the hedonic scale test, there was no difference between yogurts supplemented or not with Bifidobacterium spp., and added or not with strawberry aroma. The study showed to be possible the elaboration of goat milk yogurt supplemented with Bifidobacterium spp. and strawberry aroma, presenting safety, potential for probiotic use, and good acceptability by consumers.
